GlucoTrack Financials

Trends View

Profitability View

Liquidity View

Fundamentals View

Competition View

GlucoTrack Stock Summary

GlucoTrack competes with Nexgel, Sharps Technology, Innovative Eyewear, Predictive Oncology, and Microbot Medical. GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel. Glucotrack operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.

GlucoTrack Key Financial Ratios

GlucoTrack Key Balance Sheet Accounts

GlucoTrack Key Income Statement Accounts

GlucoTrack Key Cash Accounts

GlucoTrack Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining GlucoTrack's current stock value. Our valuation model uses many indicators to compare GlucoTrack value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GlucoTrack competition to find correlations between indicators driving GlucoTrack's intrinsic value. More Info.GlucoTrack is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, GlucoTrack's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value GlucoTrack by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

GlucoTrack Systematic Risk

Today, most investors in GlucoTrack Stock are looking for potential investment opportunities by analyzing not only static indicators but also various GlucoTrack's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of GlucoTrack growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of GlucoTrack help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of GlucoTrack. We use our internally-developed statistical techniques to arrive at the intrinsic value of GlucoTrack based on widely used predictive technical indicators. In general, we focus on analyzing GlucoTrack Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build GlucoTrack's daily price indicators and compare them against related drivers.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlucoTrack. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlucoTrack. If investors know GlucoTrack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlucoTrack listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of GlucoTrack is measured differently than its book value, which is the value of GlucoTrack that is recorded on the company's balance sheet. Investors also form their own opinion of GlucoTrack's value that differs from its market value or its book value, called intrinsic value, which is GlucoTrack's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlucoTrack's market value can be influenced by many factors that don't directly affect GlucoTrack's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between GlucoTrack's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlucoTrack is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlucoTrack's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.